Main Street Financial Solutions LLC raised its stake in The Clorox Company (NYSE:CLX – Free Report) by 13.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,527 shares of the company’s stock after purchasing an additional 542 shares during the period. Main Street Financial Solutions LLC’s holdings in Clorox were worth $735,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Brooklyn Investment Group lifted its stake in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the period. Redwood Park Advisors LLC bought a new stake in shares of Clorox in the 4th quarter worth approximately $26,000. Millstone Evans Group LLC acquired a new stake in shares of Clorox during the 4th quarter worth approximately $31,000. Asset Planning Inc bought a new stake in shares of Clorox during the fourth quarter valued at approximately $32,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of Clorox during the fourth quarter valued at approximately $33,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have weighed in on the stock. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. DA Davidson decreased their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Wells Fargo & Company dropped their price target on shares of Clorox from $155.00 to $145.00 and set an “equal weight” rating for the company in a research report on Wednesday. JPMorgan Chase & Co. decreased their price objective on Clorox from $173.00 to $151.00 and set a “neutral” rating on the stock in a report on Friday, April 11th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $154.25.
Clorox Trading Down 1.8 %
Shares of NYSE CLX opened at $136.89 on Thursday. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The company has a market cap of $16.86 billion, a PE ratio of 37.40, a P/E/G ratio of 2.62 and a beta of 0.61. The company has a 50-day moving average of $146.89 and a two-hundred day moving average of $156.79. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the company earned $2.16 earnings per share. As a group, equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.56%. Clorox’s dividend payout ratio is currently 133.33%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- Stock Sentiment Analysis: How it Works
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Top Stocks Investing in 5G Technology
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.